| Date Filed | Type | Description |
| 06/05/2023 |
4
| HOGUE GERALD L. (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 44,749 options to buy
@ $9.12, valued at
$408.1k
|
|
| 06/05/2023 |
4
| GOODMAN JONATHAN R. (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 44,749 options to buy
@ $9.12, valued at
$408.1k
|
|
| 06/05/2023 |
4
| MARGOLIN YAEL (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 44,749 options to buy
@ $9.12, valued at
$408.1k
|
|
| 06/05/2023 |
4
| Malik Rajesh (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 44,749 options to buy
@ $9.12, valued at
$408.1k
|
|
| 06/05/2023 |
4
| Lubner David Charles (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 44,749 options to buy
@ $9.12, valued at
$408.1k
|
|
| 03/30/2023 |
4
| SILBER ALLAN C (Executive Chairman) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 537,322 options to buy
@ $6.78, valued at
$3.6M
|
|
| 03/30/2023 |
4
| MCCANN JOE A. (CEO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 692,643 options to buy
@ $6.78, valued at
$4.7M
|
|
| 03/30/2023 |
4
| KELLY JUSTYNA (COO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 98,358 options to buy
@ $6.78, valued at
$666.9k
|
|
| 03/30/2023 |
4
| JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 136,055 options to buy
@ $6.78, valued at
$922.5k
|
|
| 03/30/2023 |
4
| FLESHNER NEIL E. (Chief Medical Officer) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 84,257 options to buy
@ $6.78, valued at
$571.3k
|
|
| 03/30/2023 |
4
| DEMERS WILLIAM L. (CFO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 131,355 options to buy
@ $6.78, valued at
$890.6k
|
|
| 03/23/2023 |
4
| HOGUE GERALD L. (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Exercised 17,936 options to buy
@ $6.97, valued at
$125k
|
|
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 13,766 options to buy
@ $7.91, valued at
$108.9k
|
|
| 03/31/2022 |
4
| JENSEN JESSICA D. (EVP Clinical Development) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 213,301 options to buy
@ $8.13, valued at
$1.7M
|
|
| 03/31/2022 |
4
| KELLY JUSTYNA (COO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 77,958 options to buy
@ $8.13, valued at
$633.8k
|
|
| 03/31/2022 |
4
| DEMERS WILLIAM L. (CFO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 105,360 options to buy
@ $8.13, valued at
$856.6k
|
|
| 03/31/2022 |
4
| FLESHNER NEIL E. (Chief Medical Officer) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 60,234 options to buy
@ $8.13, valued at
$489.7k
|
|
| 03/31/2022 |
4
| MCCANN JOE A. (CEO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 381,795 options to buy
@ $8.13, valued at
$3.1M
|
|
| 02/08/2022 |
4/A
| GOODMAN JONATHAN R. (Director) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 35,872 shares
@ $0 |
|
| 12/10/2021 |
4
| KELLY JUSTYNA (COO) has filed a Form 4 on POINT Biopharma Global Inc.|
Txns:
| Granted 70,000 options to buy
@ $6.4, valued at
$448k
|
|
| 12/10/2021 |
3
| KELLY JUSTYNA (COO) has filed a Form 3 on POINT Biopharma Global Inc. |
|